Improving Buprenorphine Access While Reducing Diversion

Apr 21, 2016

The Partnership for Drug Free Kids? Join Together sat down with CleanSlate Center?s Chief Medical Officer and President-elect of the American Society of Addiction Medicine, Dr. Kelly Clark, to tackle buprenorphine diversion. In it, Dr. Clark addresses the problem of buprenorphine diversion and recommends solutions to it while providing quality medical care to addiction patients including reforms to how health insurance companies provide coverage and better training for doctors so they adhere to the best treatment protocols.

For the full interview, including Dr. Clark on the 100 patient per qualified doctor limit, click here.

CleanSlate Centers

Our mission is simple: Improve the quality of life for people suffering from opioid and alcohol addictions. To date, CleanSlate has treated more than 110,000 patients across the country, working closely with our partners to save and change lives.